Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Darbepoetin alfa for Anemia in COPD (ELAB)
NCT00579046Phase 3Withdrawn
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Nov 2008
- Primary completion
- Oct 2009
- Countries
- 1
01
Overview
Phase 3, open-label trial of darbepoetin alfa in anemia, sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: 6-minute walk distance at 2 months. Planned start Nov 2008; status: withdrawn.
02
Drugs
darbepoetin alfa
03
Conditions
anemia
Beyond the preview
Go deeper on NCT00579046.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00579046.